Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2010

April 1, 2011 By Bio-Medicine.Org

ADDISON, Texas, April 1, 2011 /PRNewswire/ — ULURU Inc.
(NYSE AMEX: ULU) today announced its financial results for
the fourth quarter and year ended December 31, 2010.  

For the fourth quarter of 2010, the Company reported a net loss
of $0.3 million, or $0.004 per share, compared with a net loss of
$1.7 million, or $0.024 per share, for the same period last year.
 For the year ended December 31, 2010, the Company reported a
net loss of $5.0 million, or $0.06 per share, compared with a net
loss of $9.2 million, or $0.14 per share, in the same period of
2009. At December 31, 2010, the Company held cash and cash
equivalents of approximately $0.6 million, compared with $1.9
million at December 31, 2009.  As of March 1, 2011, the
Company held cash and cash equivalents of approximately $0.7
million.

Commenting on the financial results Kerry P. Gray,
President and CEO stated, “The 2010 results which reflect a
significant improvement in our reported loss from 2009 is due
principally to the business restructuring that occurred in July
2009. Non-recurring events accounted for $655,000 of the
improvement in 2010 with the balance being attributable to
operations. As we expand our commercial activities, both in the
U.S. and internationally, we continue to maintain tight controls of
our operating expenses. The next 6 months will be an exciting
period for the Company as we anticipate three product launches
internationally, the submission of two additional 510(k)
applications in the U.S. to expand our Altrazeal® product line,
significant expansion in Altrazeal® revenues, and additional
licensing activities. We are projecting that during this period the
Company will receive approximately $2 million from commercial
activities.”

Operating ResultsRevenues

Revenues for the fourth quarter of 2010 were $1,029,000,
compared to $233,000 for the fourth quarter of 2009.  The
increase of approximately

‘/>”/>

SOURCE

Related Articles Read More >

An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
Reconstructed 3D fluorescence image of the stained biohybrid mesh-tissue integration. The red, green, and blue colors correspond to the mesh, F-actin, and nuclei, respectively.
Researchers mesh electronics with human cells to develop living battery
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
A photo of Conexeu Sciences co-founder and Chief Scientific Officer Dr. Claudia Chavez-Munoz.
This tissue engineering scientist is bioprinting next-gen absorbable implants
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe